Wendy Blosser
Directeur Général chez ACCUSTEM SCIENCES, INC.
Fortune : 666 $ au 30/04/2024
Profil
Wendy Blosser is currently the Chief Executive Officer & Director at AccuStem Sciences, Inc. She previously held positions as Vice President-Sales at Integrated Oncology Solutions, Inc., Chief Commercial Officer at Biodesix, Inc., and Chief Commercial Officer at Agendia, Inc. From 2019 to 2021, she served as the Chief Commercial Officer at Agendia NV.
Ms. Blosser completed her undergraduate degree at Marietta College and her graduate degree at West Virginia University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ACCUSTEM SCIENCES INC
0,02% | 31/12/2023 | 2 000 ( 0,02% ) | 666 $ | 30/04/2024 |
Postes actifs de Wendy Blosser
| Sociétés | Poste | Début |
|---|---|---|
| ACCUSTEM SCIENCES, INC. | Directeur Général | 04/03/2022 |
Anciens postes connus de Wendy Blosser
| Sociétés | Poste | Fin |
|---|---|---|
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Corporate Officer/Principal | 01/03/2021 |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Corporate Officer/Principal | - |
| Integrated Oncology Solutions, Inc. | Sales & Marketing | - |
| BIODESIX, INC. | Corporate Officer/Principal | - |
Formation de Wendy Blosser
| Marietta College | Undergraduate Degree |
| West Virginia University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIODESIX, INC. | Health Services |
| ACCUSTEM SCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
| Integrated Oncology Solutions, Inc. | |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Health Services |